文献速递胃肠外科围术期管理与 ERAS

BMI≥60 kg/m²患者机器人减重手术与腹腔镜减重手术的趋势与结局:MBSAQIP 32,295例分析

Evaluating trends and outcomes between robotic and laparoscopic bariatric surgery in patients with BMI ≥ 60 kg/m2: an MBSAQIP analysis of 32,295 cases.
PubMed 文献 · Surg Endosc · 2026-03-12

基于MBSAQIP 2020-2023数据库,纳入32,295例BMI≥60 kg/m²的初次袖状胃切除或Roux-en-Y胃旁路术患者,比较机器人(R-BS)与腹腔镜(L-BS)减重手术。结果显示两组30天并发症(漏、出血、再手术、再入院)无显著差异,机器人手术时间显著更长,但机器人使用比例从20.4%升至41.3%。机器人入路既非严重并发症的独立危险因素也无保护作用。

要点

  • BMI≥60 kg/m²患者中,机器人减重手术与腹腔镜减重手术的30天并发症无显著差异。
  • 机器人手术时间显著长于腹腔镜(106.5±51.4 min vs. 83.5±47.0 min,p<0.001)。
  • 机器人减重手术使用比例从2020年20.4%增至2023年41.3%,腹腔镜相应下降。

核心结论

  • 在BMI≥60 kg/m²的择期减重手术患者中,尽管基线存在差异,腹腔镜与机器人入路的30天术后结局无显著差异。
  • 机器人入路既非严重并发症的独立危险因素,也无保护作用。
  • 该高危人群的围术期结局主要由患者合并症和手术因素决定,而非手术入路。

研究设计与样本

  • 回顾性分析2020-2023年MBSAQIP数据库,纳入32,295例BMI≥60 kg/m²的初次腹腔镜或机器人袖状胃切除(SG)和Roux-en-Y胃旁路术(RYGB)患者。
  • 比较基线人口学、手术特征和30天术后结局,采用多因素logistic回归识别严重并发症的独立预测因素。

主要发现

  • 32,295例中,腹腔镜减重手术22,211例(68.8%),机器人减重手术10,084例(31.2%)。
  • 机器人组胃食管反流病(28.6% vs. 26.1%,p<0.001)和高血压(54.7% vs. 52.8%,p=0.001)比例更高。
  • 2020至2023年,机器人减重手术比例从20.4%增至41.3%,腹腔镜从79.6%降至58.7%。
  • RYGB中机器人与腹腔镜利用率无显著差异(27.4% vs. 26.4%,p=0.059)。
  • 机器人手术时间显著更长(106.5±51.4 min vs. 83.5±47.0 min,p<0.001)。

关键数值与推荐

  • 严重并发症的独立预测因素包括:年龄较大、高血压、胃食管反流病、既往心肌梗死、治疗性抗凝、更长手术时间和RYGB。

临床怎么用

  • 对于BMI≥60 kg/m²的高危减重手术患者,选择机器人或腹腔镜入路时,短期安全性和结局无显著差异。
  • 机器人手术时间较长,应结合患者合并症和手术因素综合评估,而非仅基于入路选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bariatric surgery patients with body mass index (BMI) ≥ 60 kg/m2 present unique technical and perioperative challenges. While robotic-assisted bariatric surgery is thought to offer potential technical advantages, direct comparisons between robotic and laparoscopic approaches (R-BS and L-BS) in this population remains limited. METHODS: An analysis of the 2020-2023 MBSAQIP database was conducted and all patients with BMI ≥ 60 kg/m2 who underwent primary laparoscopic or robotic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) were included. Baseline demographics, operative characteristics, and 30-day postoperative outcomes were compared. Multivariable logistic regression identified independent predictors of serious complications. RESULTS: Of 32,295 patients, 22,211 (68.8%) were L-BS and 10,084 (31.2%) were R-BS. Significant baseline differences existed between groups, including higher rates of gastroesophageal reflux disease (28.6% vs. 26.1%, p < 0.001), and hypertension (54.7% vs. 52.8%, p = 0.001) in the R-BS group. From 2020 to 2023, the proportion of R-BS doubled from 20.4% to 41.3%, whereas the proportion of L-BS declined slightly from 79.6% to 58.7%. There was no significant difference in robotic versus laparoscopic utilization for RYGB. (27.4% vs 26.4%, p = 0.059) and operative time was significantly longer in R-BS (106.5 ± 51.4 min vs. 83.5 ± 47.0 min, p < 0.001). Rates of individual 30-day complications, including leaks, bleeding, reoperation, and readmission, were low with no significant difference between cohorts. Independent predictors of serious complications included older age, hypertension, gastroesophageal reflux disease, prior myocardial infarction, therapeutic anticoagulation, longer operative time and RYGB. The robotic approach was neither independently associated with nor protective against serious complications. CONCLUSIONS: In patients with a BMI ≥ 60 kg/m2 undergoing elective bariatric surgery, there were no significant differences in 30-day postoperative outcomes between laparoscopic and robotic approaches despite baseline patient differences between groups. Although operative times were 27% longer for the robotic approach, its utilization increased substantially over the study period. These findings suggest that perioperative outcomes in this high-risk population are primarily determined by patient comorbidities and procedural factors rather than surgical approach, and that neither approach demonstrates superior short-term safety.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kachornvitaya P, Wills MV, Barajas-Gamboa JS, et al. Evaluating trends and outcomes between robotic and laparoscopic bariatric surgery in patients with BMI ≥ 60 kg/m2: an MBSAQIP analysis of 32,295 cases. Surg Endosc. 2026. PMID: 41817616. doi:10.1007/s00464-026-12652-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。